ARPA-H: New Health Research Agency Faces Old Concerns About Disrupting Private Investment

 
• By Derrick Gingery
Geoffrey Shiu Fei Ling speaks at House hearing on ARPA-H
Geoffrey Shiu Fei Ling, CEO of On Demand Pharmaceuticals and a former DARPA program manager, testifies in favor of creating ARPA-H to speed health care innovation. • Source: screenshot

More from R&D

More from Pink Sheet